Bioprinting and regenerative medicine have emerged as transformative fields at the intersection of engineering, biology, and clinical sciences. By integrating advanced biomaterials, stem cell technologies, and computer-aided design, bioprinting enables the fabrication of three-dimensional (3D) tissues and organs with structural, mechanical, and functional fidelity. Regenerative medicine leverages these constructs to repair or replace damaged tissues, addressing the global shortage of donor organs and the limitations of conventional transplantation. Recent innovations in bioinks, vascularization strategies, and multi-material printing have accelerated progress toward functional organ fabrication. However, clinical translation faces challenges in scalability, biocompatibility, immune responses, and regulatory approval. This paper explores the engineering foundations of bioprinting, key strategies for tissue repair and organ fabrication, and pathways for clinical translation. It highlights future directions such as artificial intelligence-assisted bioprinting, organ-on-a-chip models, and personalized regenerative therapies. Ultimately, bioprinting represents a paradigm shift in medicine, offering new hope for patients suffering from organ failure and chronic diseases.